Skip to main content
The Egyptian Journal of Bronchology
Download PDF

Impacts of vitamin C and D supplement on COVID-19 treatment: possible patho-mechanisms and evidence from different countries

The Egyptian Journal of Bronchology volume 17, Article number: 13 (2023) Cite this article

Abstract

Background

A balanced diet and nutrition greatly influence our immune system’s ability and regulate the risk and severity of infections. This review presented the possible patho-mechanisms of vitamins C and D in COVID-19 immunity.

Main body

Deregulation of the immune system including the decreased level of immune boosters is invariably reported in COVID-19. Vitamin C and vitamin D are among the immune boosters; homeostasis of those was found essential for fighting against the viruses, and COVID-19 is no exception. Statistical data strengthens the statements put forth on the effects of these vitamins regarding the complications, symptoms, and mortality.

Short conclusion

A comprehensive literature review revealed that vitamin C helps to reduce and in some cases eradicate the particular symptoms that pose major risks of COVID-19 while balanced vitamin D content in COVID-19 patients has been proved to possess a negative correlation with mortality.

Background

The COVID-19 pandemic caused by SARS-CoV-2 has rampant the homeostasis of the global economy, politics, and livelihood. More than 100 million people have been affected by this infectious disease with almost 3 million deaths to date [1,2,3,4]. The clinical features of COVID-19 are varied from non-symptomatic or moderate illness to severe respiratory problems and possibly death [5]. Deregulation of the immune system including cytokine storms is found to be an important indicator of COVID-19 severity. Immune-boosting therapeutics and diet are found to play an important role to fight COVID-19. The deficiency of immune-boosting vitamins C and D is reported to increase the risk and severity of COVID-19 [6]. Vitamin C and vitamin D supplement stimulates antiviral activity and prevents cytokine storms in COVID-19 patients and results in a good outcome [7].

In this review, we will highlight the underlying mechanisms of vitamin C and vitamin D in boosting antiviral activity and preventing cytokine storms in COVID-19 patients. We also summarize aggregative evidence of both vitamins’ work against COVID-19.

Main text

Mechanisms of vitamin C in antiviral activity and preventing cytokine storm

Vitamin C, also known as ascorbic acid, is an essential component for the growth, development, and repair of the body [8]. It acts as a multi-regulator in our body to protect and reduce the severity of various diseases. The immunomodulatory activity of vitamin C plays a role in both innate and adaptive immunity which can protect the physical tissue barrier [9]. It performs an important part in tissue repair by down-regulating the cytokines and safeguarding the endothelium from oxidant injury [9].

Vitamin C activates neutrophils including TNF and IL-1β, which activates the inhibitor nuclear transcription factor kappa B (NFkB), and stops the cytokine production in the alveolar space (Fig. 1). On the other hand, activation of TNF and IL-1β blocks NETosis (neutrophil extracellular trap) that hampers the cytokine production in the alveolar space [10]. As a result, a cytokine storm does not take place. Moreover, vitamin C helps in the development and maturation of T lymphocytes during the period of infection [9]. Matured lymphocytes and macrophages also help to decrease the number of cytokines and protect from cytokine storms (10, Fig. 1).

Fig. 1
figure 1

Vitamin C. Its immunomodulatory activities prevent the formation of cytokine storms in two ways. a It activates neutrophils (TNF and IL-1β) which block neutrophil extracellular trap (NETosis) in the alveolar space. On the other hand, the neutrophils also inhibit nuclear transcription factor kappa B (NFkB). These two ways prevent the formation of cytokines in the body. b Vitamin C also matures lymphocytes and macrophages in the prevention of cytokine storms. Moreover, vitamin C has anti-inflammatory activities, reduces reactive oxidative species (ROS), and protects the epithelial barrier. These activities of vitamin C protect the body from diseases and also reduce the severity of diseases

Full size image

The antioxidant activity of vitamin C reduces oxidative stress by decreasing reactive oxidative species (ROS) [9, 11]. Moreover, the antioxidant activity of vitamin C helps to protect the epithelial barrier [11]. On the other hand, vitamin C acts as a cofactor for many enzymes and helps the biosynthesis of hormones such as norepinephrine, catecholamines, and vasopressin; methylation of DNA; and histones [11]. Vitamin C also has antimicrobial properties (such as antifungal, antibacterial, and antiviral) which protect the body from diseases [12].

Mechanisms of vitamin D in antiviral activity and preventing cytokine storm

Vitamin D is a fat-soluble vitamin, responsible for calcium homeostasis and bone metabolism. In addition, vitamin D plays an important role in boosting immunity and reducing the severity of many infectious diseases. Vitamin D helps the maturation and differentiation of monocytes and macrophages and plays a role in the production of T lymphocytes [13]. Unfortunately, billions of people around the world are reported to have a deficiency in vitamin D and are prone to many infectious diseases [14].

Vitamin D also has anti-inflammatory features and can inhibit the expression of pro-inflammatory cytokines including IL-10, IL-21, and IL-1 s with help of macrophage and T-cells, as a result, preventing cytokine storms [11, 15] (Fig. 2).

Fig. 2
figure 2

Vitamin D. It has three activities. a It has immunomodulatory activity. Here, it matures lymphocytes and macrophage. b Its anti-inflammatory activity decreases the level of IL-1, IL-10, and IL-21. As a result, the level of cytokine decreases. c In its antiviral activity, vitamin C increases the level of cathelicidin (LL-37) which attacks viruses. Vitamin D helps to protect the body from diseases and reduce the severity of diseases

Full size image

Vitamin D exhibits antiviral activity. When the viral infection increases, vitamin D gets activated and helps increase the production of antimicrobial peptide cathelicidin (LL-37) and reduce the viral infection [13, 16].

Evidence of vitamin C in reducing COVID-19 severity

The immune-modulatory and antimicrobial activity made vitamin C an important factor in many chronic and infectious diseases [17]. Most studies have reported that a high dose of vitamin C supplement correlated with reduced infection and inflammation susceptibility and lower hospitalization and requirement for mechanical ventilation, as well as reduced mortality (Table 1). On the other hand, a low dose of vitamin C has been shown to cause an insignificantly lower level of thrombosis (Table 1).

Table 1 Effectiveness of vitamin C supplement in COVID-19 treatment in different populations
Full size table

Role of vitamin D

The optimum performance of our immune system is incredibly influenced by vitamin D. Its insufficiency has been associated with a vulnerability to respiratory infections [36, 37]. The necessary amount of vitamin D for our bodies is obtained via food supplements or sunlight. 7-Dehydrocholesterol, the precursor to vitamin D, becomes active when sunlight contacts the skin, and the ultraviolet B (UVB) rays then transform it into vitamin D3. Vitamins D2 and D3 are transformed by our liver into 25-hydroxyvitamin D3 [25(OH)D3]. COVID-19 patients with vitamin D deficiency exhibited increased infection and susceptibility, higher mortality, and increased ARDS. Vitamin D supplement has been found to lower viral multiplication and lower susceptibility and inflammation and ICU need (Table 2).

Table 2 Effectiveness of vitamin D supplement in COVID-19 treatment in different populations
Full size table

Summary

Compilation of the comprehensive literature studies revealed that supplementation of vitamin C and vitamin D at an early stage of COVID-19 infection is highly beneficial for patients. Interestingly, both the vitamin C and vitamin D supplement work better if given in high doses for a long period. More critical and hospitalized COVID-19 patients were also found associated with vitamin C and vitamin D deficiency. However, studies undertaken by different groups on various populations report heterogenous outcomes of vitamin C and D supplements. Additionally, different physicians prescribed different doses and courses of vitamins C and D, which indicates the requirement for precise guidelines. The studied population size was also too small to make any concrete decision. Intravenous supplementation of vitamin C and vitamin D works better than taken orally. Efficacy and safety are the two major concerns for treating COVID-19 patients with vitamins C and D. As the rate of vitamin C metabolism in blood is high, larger doses along with longer courses of vitamin C are recommended. A high dose of vitamin C has been used for decades. Recently, an NIH expert panel states that a high dose of vitamin C (1.5 g/kg body weight) is safe without major adverse effects (https://www.cancer.gov/about-cancer/treatment/cam/hp/vitamin-c-pdq). None of the trials revealed any major side effects of using high doses of vitamins C and D in the patient’s body. On the other hand, it is obvious that the result may vary with different populations and patients with other comorbidities [46,47,48,49]; thus, more detailed studies are required. Apart from the COVID-19 treatment, vitamin C is generally safe. But for some people, it may cause stomach cramps, nausea, and headache. Taking more than 2000 mg/per day is unsafe and may cause kidney stones and severe diarrhea. Similarly, a high dose of vitamin D can cause stomach discomfort, unusual symptoms, or kidney problems. Thus, COVID-19 patients are prescribed to take vitamins C and D as per doctor’s advice.

Conclusions

Mode of administration, dosage, initiation time, treatment duration, disease type, and disease progression play an effective role in the results of the studies regarding the effectiveness of vitamin C and vitamin D on COVID-19. Despite not getting any significant results, there is still a possibility to find the effectiveness of these two vitamins on COVID-19 as the results were not fully negative. As no significant side effects were observed, vitamin C and D supplement may be advised specially for hospitalized critical COVID-19 patients.

Availability of data and materials

Not applicable.

References

  1. Araf Y, Faruqui NA, Anwar S, Hosen MJ (2021) SARS-CoV-2: a new dimension to our understanding of coronaviruses. Int Microbiol 24(1):19–24

    Article  CAS  PubMed  Google Scholar 

  2. Akter F, Araf Y, Hosen MJ (2021) Corticosteroids for COVID-19: worth it or not? Mol Biol Rep 13:1

    Google Scholar 

  3. Araf Y, Akter F, Tang YD, Fatemi R, Parvez SA, Zheng C, Hossain G. Omicron variant of SARS‐CoV‐2: genomics, transmissibility, and responses to current COVID‐19 vaccines. J Med Virol. 2022. 94:1825.

  4. Ullah M, Islam H, Rahman A, Masud J, Shweta D, Araf Y et al. A generalized overview of SARS-CoV-2: where does the current knowledge stand?. E J Gen Med. 2020;17(6): em251.

  5. Ao G, Li J, Yuan Y, Wang Y, Nasr B, Bao M, Gao M, Qi X (2022) Intravenous vitamin C use and risk of severity and mortality in COVID-19: a systematic review and meta-analysis. Nutr Clin Pract 37(2):274–281. https://doi.org/10.1002/ncp.10832

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Lotfi F, Akbarzadeh-Khiavi M, Lotfi Z, Rahbarnia L, Safary A, Zarredar H, Baghbanzadeh A, Naghili B, Baradaran B (2021) Micronutrient therapy and effective immune response: a promising approach for management of COVID-19. Infection 49(6):1133–1147. https://doi.org/10.1007/s15010-021-01644-3

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Farzana M, Shahriar S, Jeba F, Tabassum T, Araf Y, Ullah M et al. Functional food: complementary to fight against COVID-19. Beni-Suef Univ J Basic Appl Sci. 2022;11(1):33.

  8. The benefits of vitamin C. (2008). WebMD. https://www.webmd.com/diet/features/the-benefits-of-vitamin-c. Accessed 24 Jan 2023.

  9. Holford P, Carr AC, Jovic TH, Ali SR, Whitaker IS, Marik PE, Smith AD (2020) Vitamin C—an adjunctive therapy for respiratory infection, sepsis and COVID-19. Nutrients 12(12):3760. https://doi.org/10.3390/nu12123760

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Shahbaz U, Fatima N, Basharat S, Bibi A, Yu X, Hussain MI, Nasrullah M (2022) Role of vitamin C in preventing of COVID-19 infection, progression and severity. AIMS microbiology 8(1):108–124. https://doi.org/10.3934/microbiol.2022010

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Name JJ, Souza ACR, Vasconcelos AR, Prado PS, Pereira CPM (2020) Zinc, vitamin D and vitamin C: perspectives for COVID-19 with a focus on physical tissue barrier integrity. Front Nutr. 7:606398. 10.3389/fnut.2020.606398

  12. Farjana M, Moni A, Sohag AAM, Hasan A, Hannan MA, Hossain MG, Uddin MJ (2020) Repositioning vitamin C as a promising option to alleviate complications associated with COVID-19. Infect Chemotherapy 52(4):461. https://doi.org/10.3947/ic.2020.52.4.461

    Article  CAS  Google Scholar 

  13. Hughes DA, Norton R (2009) Vitamin D and respiratory health. Clin Exp Immunol 158(1):20–25. https://doi.org/10.1111/j.1365-2249.2009.04001.x

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Sizar O, Khare S, Goyal A, et al. Vitamin D deficiency. [Updated 2022 Jul 18]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK532266/. Accessed 24 Jan 2023

  15. Bayraktar N, Turan H, Bayraktar M, Ozturk A, Erdoğdu H (2021) Analysis of serum cytokine and protective vitamin D levels in severe cases of COVID-19. J Med Virol 94(1):154–160. https://doi.org/10.1002/jmv.27294

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Barlow PG, Findlay EG, Currie SM, Davidson DJ (2014) Antiviral potential of cathelicidins. Future Microbiol 9(1):55–73. https://doi.org/10.2217/fmb.13.135

    Article  CAS  PubMed  Google Scholar 

  17. Ahmad, Siti Rohaiza (2022) “Vitamin C for COVID-19 treatment: have we got enough evidence? - PMC.” PubMed Central (PMC), www.ncbi.nlm.nih.gov, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9161352/. Accessed 24 Jan 2023

  18. Gao, D., Xu, M., Wang, G., Lv, J., Ma, X., Guo, Y., Zhang, D., Yang, H., Jiang, W., Deng, F., Xia, G., Lu, Z., Lv, L., & Gong, S. (2021). The efficiency and safety of high-dose vitamin C in patients with COVID-19: a retrospective cohort study. Aging, 13(5), 7020–7034. https://doi.org/10.18632/aging.202557

  19. Tehrani, S., Yadegarynia, D., Abrishami, A., Moradi, H., Gharaei, B., Rauofi , M., Maghsoudi Nejad, F., Sali, S., Khabiri, N., & Abolghasemi, S. (2021). An investigation into the effects of intravenous vitamin C on pulmonary CT findings and clinical outcomes of patients with COVID 19 pneumonia a randomized clinical trial. Urol J, 18, 6863. https://doi.org/10.22037/uj.v18i.6863

  20. Zhang, J., Rao, X., Li, Y., Zhu, Y., Liu, F., Guo, G., Luo, G., Meng, Z., de Backer, D., Xiang, H., & Peng, Z. (2021). Pilot trial of high-dose vitamin C in critically ill COVID-19 patients. Ann Intensive Care, 11(1). https://doi.org/10.1186/s13613-020-00792-3

  21. Vollbracht, C., & Kraft, K. (2022). Oxidative stress and hyper-inflammation as major drivers of severe COVID-19 and long COVID: implications for the benefit of high-dose intravenous vitamin C. Frontiers in Pharmacology, 13. https://doi.org/10.3389/fphar.2022.899198

  22. Yang X, Wang Y, Liu Y, Shang L, Cheng Z, Fang L, Zhang J, Feng Y, Zhang K, Jiang S, He X (2022) Traditional Chinese medicine together with high-dose vitamin C improves the therapeutic effect of western medicine against COVID-19. Am J Transl Res 14(1):501–510

    CAS  PubMed  PubMed Central  Google Scholar 

  23. Xia, G., Fan, D., He, Y., Zhu, Y., & Zheng, Q. (2021). High-dose intravenous vitamin C attenuates hyperinflammation in severe coronavirus disease 2019. Nutrition, 91–92, 111405. https://doi.org/10.1016/j.nut.2021.111405

  24. Patel, J. J., Ortiz-Reyes, A., Dhaliwal, R., Clarke, J., Hill, A., Stoppe, C., Lee, Z. Y., & Heyland, D. K. (2021). IV vitamin C in critically ill patients. Critical Care Medicine, Publish Ahead of Print. https://doi.org/10.1097/ccm.0000000000005320

  25. Hess, A. L., Halalau, A., Dokter, J. J., Paydawy, T. S., Karabon, P., Bastani, A., Baker, R. E., Balla, A. K., & Galens, S. A. (2022). High-dose intravenous vitamin C decreases rates of mechanical ventilation and cardiac arrest in severe COVID-19. Internal Emerg Med, 1–10. Advance online publication. https://doi.org/10.1007/s11739-022-02954-6

  26. Coppock D, Violet PC, Vasquez G, Belden K, Foster M, Mullin B, Magee D, Mikell I, Shah L, Powers V, Curcio B, Daskalakis C, Monti D, Levine M (2022) Pharmacologic ascorbic acid as early therapy for hospitalized patients with COVID-19: a randomized clinical trial. Life (Basel, Switzerland) 12(3):453. https://doi.org/10.3390/life12030453

    Article  CAS  PubMed  Google Scholar 

  27. Jamali MoghadamSiahkali, S., Zarezade, B., Koolaji, S., SeyedAlinaghi, S., Zendehdel, A., Tabarestani, M., Sekhavati Moghadam, E., Abbasian, L., Dehghan Manshadi, S. A., Salehi, M., Hasannezhad, M., Ghaderkhani, S., Meidani, M., Salahshour, F., Jafari, F., Manafi, N., & Ghiasvand, F. (2021). Safety and effectiveness of high-dose vitamin C in patients with COVID-19: a randomized open-label clinical trial. Eur J Med Res, 26(1). https://doi.org/10.1186/s40001-021-00490-1

  28. Li, M., Ching, T. H., Hipple, C., Lopez, R., Sahibzada, A., & Rahman, H. (2021). Use of intravenous vitamin C in critically ill patients with COVID-19 infection. J Pharmacy Pract, 089719002110150. https://doi.org/10.1177/08971900211015052

  29. Suna K, Melahat UE, Murat Y, Figen ZE, Ayperi Z (2022) Effect of high-dose intravenous vitamin C on prognosis in patients with SARS-CoV-2 pneumonia. Medicina Clínica (English Edition) 158(8):356–360. https://doi.org/10.1016/j.medcle.2021.04.027

    Article  CAS  PubMed  Google Scholar 

  30. al Sulaiman, K., Aljuhani, O., Saleh, K. B., Badreldin, H. A., al Harthi, A., Alenazi, M., Alharbi, A., Algarni, R., al Harbi, S., Alhammad, A. M., Vishwakarma, R., & Aldekhyl, S. (2021). Ascorbic acid as an adjunctive therapy in critically ill patients with COVID-19: a propensity score matched study. Sci Rep, 11(1). https://doi.org/10.1038/s41598-021-96703-y

  31. Kumari P, Dembra S, Dembra P, Bhawna F, Gul A, Ali B, Sohail H, Kumar B, Memon MK, Rizwan A (2020) The role of vitamin C as adjuvant therapy in COVID-19. Cureus. https://doi.org/10.7759/cureus.11779

    Article  PubMed  PubMed Central  Google Scholar 

  32. Zheng S, Chen Q, Jiang H, Guo C, Luo J, Li S, Wang H, Li H, Zheng X, Weng Z (2021) No significant benefit of moderate-dose vitamin C on severe COVID-19 cases. Open Medicine 16(1):1403–1414. https://doi.org/10.1515/med-2021-0361

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Kwak, S. G., Choo, Y. J., & Chang, M. C. (2022). The effectiveness of high-dose intravenous vitamin C for patients with coronavirus disease 2019: a systematic review and meta-analysis. Complement Therap Med, 64: 102797. https://doi.org/10.1016/j.ctim.2021.102797

  34. Beigmohammadi, M. T., Bitarafan, S., Hoseindokht, A., Abdollahi, A., Amoozadeh, L., & Soltani, D. (2021). The effect of supplementation with vitamins A, B, C, D, and E on disease severity and inflammatory responses in patients with COVID-19: a randomized clinical trial. Trials, 22(1). https://doi.org/10.1186/s13063-021-05795-4

  35. Hiedra R, Lo KB, Elbashabsheh M, Gul F, Wright RM, Albano J, Azmaiparashvili Z, Patarroyo Aponte G (2020) The use of IV vitamin C for patients with COVID-19: a case series. Expert Rev Anti Infect Ther 18(12):1259–1261. https://doi.org/10.1080/14787210.2020.1794819

    Article  CAS  PubMed  Google Scholar 

  36. Pugach IZ, Pugach S (2021) Strong correlation between prevalence of severe vitamin D deficiency and population mortality rate from COVID-19 in Europe. Wien Klin Wochenschr 133(7–8):403–405. https://doi.org/10.1007/s00508-021-01833-y

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Dissanayake, Harsha Anuruddhika, et al.  (2022)“Prognostic and therapeutic role of vitamin D in COVID-19: systematic review and meta-analysis | J Clin Endocrinol Metabol | Oxford Academic.” OUP Academic, academic.oup.com, https://academic.oup.com/jcem/article/107/5/1484/6459715?login=true. Accessed 24 Jan 2023

  38. Cosdon, Nina. “Vitamin D deficiency increases risk of severe or fatal COVID-19.” Contagion Live, www.contagionlive.com, https://www.contagionlive.com/view/vitamin-d-deficiency-increases-risk-of-severe-or-fatal-covid-19. Accessed 24 Jan 2023

  39. Quesada-Gomez JM, Entrenas-Castillo M, Bouillon R. Vitamin D receptor stimulation to reduce acute respiratory distress syndrome (ARDS) in patients with coronavirus SARS-CoV-2 infections: revised Ms SBMB 2020_166. J Steroid Biochem Mol Biol. 2020;202:105719. doi:https://doi.org/10.1016/j.jsbmb.2020.105719

  40. Ghasemian, Roya, Amir Shamshirian, Keyvan Heydari, Mohammad Malekan, Reza Alizadeh-Navaei, Mohammad Ali Ebrahimzadeh, Majid Ebrahimi Warkiani, et al. 2021. “The role of vitamin D in the age of COVID-19: a systematic review and meta-analysis.” Int J Clin Pract, e14675. https://doi.org/10.1111/ijcp.14675.

  41. Nogues X, Ovejero D, Pineda-Moncusí M et al (2021) Calcifediol treatment and COVID-19-related outcomes. J Clin Endocrinol Metab 106(10):e4017–e4027. https://doi.org/10.1210/clinem/dgab405

    Article  PubMed  Google Scholar 

  42. Bassatne A, Basbous M, Chakhtoura M, El Zein O, Rahme M, El-Hajj Fuleihan G.  (2021) The link between COVID-19 and VItamin D (VIVID): a systematic review and meta-analysis. Metabolism. 119:154753. doi:https://doi.org/10.1016/j.metabol.2021.154753

  43. Brito DTM, Ribeiro LHC, Daltro CHDC, Silva RB. (2021). The possible benefits of vitamin D in COVID-19. Nutrition. 91–92:111356. doi:https://doi.org/10.1016/j.nut.2021.111356

  44. Giannini S, Giusti A, Minisola S, et al. (2022) The immunologic profile of vitamin D and its role in different immune-mediated diseases: an expert opinion. Nutrients. 14(3):473. Published 2022 Jan 21. doi:https://doi.org/10.3390/nu14030473

  45. Lotfi, Fariba, et al. (2021) “Micronutrient therapy and effective immune response: a promising approach for management of COVID-19 - infection.” SpringerLink, link.springer.com, https://doi.org/10.1007/s15010-021-01644-3.

  46. Gavrielatou, E., Xourgia, E., Xixi, N. A., Mantelou, A. G., Ischaki, E., Kanavou, A., Zervakis, D., Routsi, C., Kotanidou, A., & Siempos, I. I. (2022). Effect of vitamin C on clinical outcomes of critically ill patients with COVID-19: an observational study and subsequent meta-analysis. Front Med, 9. https://doi.org/10.3389/fmed.2022.814587

  47. Ali N (2020) Role of vitamin D in preventing of COVID-19 infection, progression and severity. J Infect Public Health 13(10):1373–1380. https://doi.org/10.1016/j.jiph.2020.06.021

    Article  PubMed  PubMed Central  Google Scholar 

  48. Khan, Aysha Habib, et al. (2021) “Vitamin D and COVID-19: is there a role? - Journal of Diabetes & Metabolic Disorders.” SpringerLink, link.springer.com, https://doi.org/10.1007/s40200-021-00775-6.

  49. Pardhan, Shahina, et al. “Frontiers | Vitamin D deficiency as an important biomarker for the increased risk of coronavirus (COVID-19) in people from Black and Asian Ethnic Minority Groups.” Frontiers, https://www.frontiersin.org/articles/, 1 Jan. 2001, https://doi.org/10.3389/fpubh.2020.613462/full.

Download references

Acknowledgements

The authors acknowledge the members of the Community of Biotechnology, Dhaka, Bangladesh, for their support during the preparation of the manuscript.

Funding

No specific grant was received for this study. MJH received grants from the SUST Research Center (LS/2020/15).

Author information

Author notes

  1. Sohel Ahmed, Mehrin Hossain and Deepita Chakrabortty are shared first authors.

Authors and Affiliations

  1. Department of Chemistry, Shahjalal University of Science and Technology, Sylhet, 3114, Bangladesh

    Sohel Ahmed & Mohammad Mizanur Rahman Khan

  2. Biotechnology Program, Department of Mathematics and Natural Sciences, School of Data and Sciences, BRAC University, Dhaka, Bangladesh

    Mehrin Hossain & Deepita Chakrabortty

  3. Department of Biotechnology and Genetic Engineering, Bangabandhu Sheikh Mujibur Rahman Science and Technology University, Gopalganj, Bangladesh

    Kazi Ifthi Arafat

  4. Department of Genetic Engineering and Biotechnology, Shahjalal University of Science and Technology, Sylhet, 3114, Bangladesh

    Mohammad Jakir Hosen

Authors
  1. Sohel Ahmed
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mehrin Hossain
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Deepita Chakrabortty
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kazi Ifthi Arafat
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Mohammad Jakir Hosen
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Mohammad Mizanur Rahman Khan
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

MK conceived the study. MJH designed the study. MH and DC wrote the draft manuscript. KA, MK, and MJH edited and revised the manuscript. All the authors approved the final version of the manuscript.

Corresponding authors

Correspondence to Mohammad Jakir Hosen or Mohammad Mizanur Rahman Khan.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ahmed, S., Hossain, M., Chakrabortty, D. et al. Impacts of vitamin C and D supplement on COVID-19 treatment: possible patho-mechanisms and evidence from different countries. Egypt J Bronchol 17, 13 (2023). https://doi.org/10.1186/s43168-023-00186-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s43168-023-00186-6

Keywords